- Home
- KROS vs PBT Comparison
KROS vs PBT Comparison
Compare KROS & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- PBT
- Stock Information
- Founded
- KROS 2015
- PBT 1980
- Country
- KROS United States
- PBT United States
- Employees
- KROS N/A
- PBT N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- PBT Oil & Gas Production
- Sector
- KROS Health Care
- PBT Energy
- Exchange
- KROS Nasdaq
- PBT Nasdaq
- Market Cap
- KROS 558.9M
- PBT 562.6M
- IPO Year
- KROS 2020
- PBT N/A
- Fundamental
- Price
- KROS $14.53
- PBT $12.94
- Analyst Decision
- KROS Buy
- PBT
- Analyst Count
- KROS 13
- PBT 0
- Target Price
- KROS $20.63
- PBT N/A
- AVG Volume (30 Days)
- KROS 477.3K
- PBT 151.7K
- Earning Date
- KROS 08-06-2025
- PBT 01-01-0001
- Dividend Yield
- KROS N/A
- PBT 4.21%
- EPS Growth
- KROS N/A
- PBT N/A
- EPS
- KROS 0.11
- PBT 0.48
- Revenue
- KROS $214,713,000.00
- PBT $24,140,674.00
- Revenue This Year
- KROS $5,006.76
- PBT N/A
- Revenue Next Year
- KROS N/A
- PBT N/A
- P/E Ratio
- KROS $132.80
- PBT $26.51
- Revenue Growth
- KROS 91657.70
- PBT N/A
- 52 Week Low
- KROS $9.12
- PBT $8.01
- 52 Week High
- KROS $72.37
- PBT $14.26
- Technical
- Relative Strength Index (RSI)
- KROS 64.67
- PBT 65.87
- Support Level
- KROS $13.26
- PBT $12.66
- Resistance Level
- KROS $14.68
- PBT $13.73
- Average True Range (ATR)
- KROS 0.41
- PBT 0.38
- MACD
- KROS 0.12
- PBT 0.00
- Stochastic Oscillator
- KROS 89.35
- PBT 59.49
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.